Michael Zdzislaw Kasperkiewicz

Michael Kasperkiewicz practices at Santa Monica Surgicenter in Santa Monica, California.

Michael Kasperkiewicz's NPI, 1265099097, was assigned on May 28, 2019. Michael Kasperkiewicz graduated from University Hamburg, Krankenhaus Eppendorf, Fak Med in 2004. Michael Kasperkiewicz holds California license A184360.

Michael Kasperkiewicz's primary practice is Santa Monica Surgicenter, at 2001 Santa Monica Blvd, Santa Monica, CA 90404 in Los Angeles County. The practice phone is (310) 829-5550.

Michael Kasperkiewicz's primary practice is Santa Monica Surgicenter in Santa Monica, California. Michael Kasperkiewicz is also affiliated with UCLA Santa Monica Medical Center. The medical group on file is USC Care Medical Group. Dmand AI also links Michael Kasperkiewicz to 1 more hospital, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Michael Kasperkiewicz practices, 5 sites in all. Vendor and product names are available with a free account.

Dermatology is Michael Kasperkiewicz's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Michael Kasperkiewicz is licensed in California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, itchy rashes, rash, scalp rash, shingles and skin cyst among the conditions Michael Kasperkiewicz treats.

CMS data shows 608 Medicare services from Michael Kasperkiewicz across 8 procedure codes in 2024, for 316 Medicare patients. Medicare paid $46,499 for them. Every service was in an office.

CMS counts 316 Medicare patients who saw Michael Kasperkiewicz in 2024. The largest group is 65 to 74, with 138 patients. 72% of them have high cholesterol, and 70% have high blood pressure. 35% are also on Medicaid. Their average risk score is 1.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Michael Kasperkiewicz's median patient age at 52, with 51% women.

In 2024, Michael Kasperkiewicz wrote 662 Medicare Part D claims for 234 patients. 93% of them were for generic drugs. CMS names the drug for 533 of them, across 15 drugs with 11 or more claims each, at $76,356 in total drug cost. In 2023, CMS named 303 claims across 11 drugs.

Michael Kasperkiewicz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Michael Kasperkiewicz as offering telehealth. CMS counts 415 procedures of removal of skin lesions by Michael Kasperkiewicz, more than 85% of the clinicians it reports for that procedure.

Dmand AI links 39 papers to Michael Kasperkiewicz, published from 2009 to 2024. 2013 was the busiest year, with 5. The most frequent topics are Autoantibodies, Pemphigoid, Bullous and Skin Diseases, Vesiculobullous. Michael Kasperkiewicz has published most often in Hautarzt. Michael Kasperkiewicz's most frequent co-authors are Olivia Yu-Ping Lai, MD, Nada M. Elbuluk, MD and Christoph Thomas Ellebrecht, MD.

CMS Open Payments shows 10 general payments to Michael Kasperkiewicz from 5 drug and device companies from 2023 to 2025. Food and beverage make up the largest share, 100% of the total. Sanofi and Genzyme US Companies paid the most, $283.

Michael Kasperkiewicz graduated from University Hamburg, Krankenhaus Eppendorf, Fak Med in 2004.

Michael Kasperkiewicz is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.